California AB242 expands newborn genetic disease screening to include additional conditions.

California AB242 amends the Health and Safety Code to expand the state's newborn genetic disease screening program. The bill requires the California Department of Public Health to include screening for adrenoleukodystrophy, Duchenne muscular dystrophy, and severe combined immunodeficiency in its Genetic Disease Branch Screening Information System. It also mandates screening for fatty acid oxidation, amino acid, organic acid disorders, and congenital adrenal hyperplasia.

California AB242 expands newborn genetic disease screening to include additional conditions.

California AB242 amends the Health and Safety Code to expand the state's newborn genetic disease screening program. The bill requires the California Department of Public Health to include screening for adrenoleukodystrophy, Duchenne muscular dystrophy, and severe combined immunodeficiency in its Genetic Disease Branch Screening Information System. It also mandates screening for fatty acid oxidation, amino acid, organic acid disorders, and congenital adrenal hyperplasia.